BRD4 in physiology and pathology: ‘‘BET’’ on its partners
Author:
Affiliation:
1. State Key Laboratory of Natural Medicines Jiangsu Key Laboratory of Carcinogenesis and Intervention School of Basic Medicine and Clinical Pharmacy China Pharmaceutical University Nanjing People's Republic of China
Funder
National Natural Science Foundation of China
Publisher
Wiley
Subject
General Biochemistry, Genetics and Molecular Biology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/bies.202100180
Reference135 articles.
1. Bromodomain biology and drug discovery
2. Beating the odds: BETs in disease
3. Cooperative binding of two acetylation marks on a histone tail by a single bromodomain
4. Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains
5. Targeting bromodomains: epigenetic readers of lysine acetylation
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Apabetalone (RVX-208): A Potential Epigenetic Therapy for the Treatment of Cardiovascular, Renal, Neurological, Viral, and Cancer Disorders;ACS Pharmacology & Translational Science;2024-02-06
2. The epigenetic regulatory effect of histone acetylation and deacetylation on skeletal muscle metabolism-a review;Frontiers in Physiology;2023-12-08
3. BRD4-binding enhancer promotes CRC progression by interacting with YY1 to activate the Wnt pathway through upregulation of TCF7L2;Biochemical Pharmacology;2023-12
4. Potentially active compounds that improve PAD through angiogenesis: A review;Biomedicine & Pharmacotherapy;2023-12
5. BRD4 as a potential target for human papillomaviruses associated cancer;Journal of Medical Virology;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3